601336:SSENew China Life Insurance Co., Ltd. Class A Analysis
Data as of 2026-06-02 - not real-time
CN¥57.71
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Technical outlook: The stock trades at CNY 57.71, barely above the computed support level of CNY 57.20 and well below the 20‑day (CNY 61.23), 50‑day (CNY 62.48) and 200‑day (CNY 68.03) moving averages, signaling a bearish trend. Momentum indicators reinforce this view – the 14‑day RSI sits at 34.9 (near‑oversold) and the MACD histogram is negative, with the MACD line (‑1.52) under the signal line (‑1.37).
Fundamental backdrop: Valuation appears attractive: the trailing P/E of 4.88 is far below the industry average of 16.65, while the P/B ratio of 1.46 suggests modest premium to book. Profitability is strong (gross margin 60.6%, operating margin 50%, profit margin 49%) and ROE is an impressive 36%. The dividend yield of 4.53% is supported by a low payout ratio of 22.5%, indicating sustainability despite a negative free‑cash‑flow figure. However, leverage is high (debt‑to‑equity ≈ 103%) and 30‑day volatility is elevated at 21.8%, which tempers the upside potential.
Fundamental backdrop: Valuation appears attractive: the trailing P/E of 4.88 is far below the industry average of 16.65, while the P/B ratio of 1.46 suggests modest premium to book. Profitability is strong (gross margin 60.6%, operating margin 50%, profit margin 49%) and ROE is an impressive 36%. The dividend yield of 4.53% is supported by a low payout ratio of 22.5%, indicating sustainability despite a negative free‑cash‑flow figure. However, leverage is high (debt‑to‑equity ≈ 103%) and 30‑day volatility is elevated at 21.8%, which tempers the upside potential.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above technical support
- Bearish MACD and RSI indicating limited upside
- Attractive dividend yield for income‑focused investors
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation discount (P/E 4.9 vs industry 16.7)
- Strong profitability and high ROE
- Sustainable dividend providing cash‑flow cushion
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Demographic tailwinds for life‑insurance demand in China
- Consistently high profit margins and capital generation
- Undervalued price offering long‑run upside despite leverage
Key Metrics & Analysis
Financial Health
Revenue Growth3.20%
Profit Margin49.13%
P/E Ratio4.9
ROE36.28%
ROA1.44%
Debt/Equity102.56
P/B Ratio1.5
Op. Cash FlowCN¥113.6B
Free Cash FlowCN¥-157396992000
Industry P/E16.7
Technical Analysis
TrendBearish
RSI34.9
SupportCN¥57.20
ResistanceCN¥66.57
MA 20CN¥61.23
MA 50CN¥62.48
MA 200CN¥68.03
MACDBearish
VolumeStable
Fear & Greed Index93.11
Valuation
Fair ValueCN¥570.42
GradeUndervalued
TypeValue
Dividend Yield4.53%
Risk Assessment
Beta0.59
Volatility21.82%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.